Literature DB >> 22762895

Depressive symptoms and cortisol variability prior to surgery for suspected endometrial cancer.

Timothy S Sannes1, Sally E Jensen, Stacy M Dodd, Shawn M Kneipp, Stephanie Garey Smith, Seema M Patidar, Michael M Marsiske, Susan M Lutgendorf, Linda S Morgan, Deidre B Pereira.   

Abstract

Endometrial cancer (EC) is the most common type of gynecologic cancer affecting women; however, very little research has examined relationships between psychological factors and hypothalamic-pituitary-adrenal (HPA) axis dysregulation in this population. The current study examined relations between depressive/anxious symptoms and salivary cortisol diurnal rhythm and variability in women undergoing surgery for suspected endometrial cancer. Depressive and anxious symptoms were measured prior to surgery using the Structured Interview Guide for the Hamilton Depression Inventory (SIGH-AD). Saliva was collected four times a day for the 3 days prior to surgery and then assayed by ELISA to obtain cortisol concentrations. Cortisol slopes and intraindividual variability were then calculated across subjects. Relations between depressive/anxious symptoms and cortisol indices were examined using multilevel modeling and linear regression analyses. Participants were 82 women with nonmetastatic endometrial cancer. Anxious symptoms were not associated with either cortisol slope or intraindividual variability, and depressive symptoms were unrelated to cortisol slope. However, after controlling for presence of poorer prognosis cancer subtypes, greater depressive symptoms (excluding symptoms possibly/definitely due to health/treatment factors) in the week preceding surgery were significantly related to greater cortisol intraindividual variability (β=.214; p<.05). These results suggest that depressive symptoms prior to surgery for suspected endometrial cancer are related to greater cortisol intraindividual variability, which is suggestive of more erratic HPA axis arousal. Future research should examine whether mood symptoms may be associated with compromised health outcomes via erratic HPA axis arousal in this population.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762895      PMCID: PMC3473116          DOI: 10.1016/j.psyneuen.2012.06.001

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  40 in total

1.  Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer.

Authors:  Janine Giese-Davis; Sandra E Sephton; Heather C Abercrombie; Ron E F Durán; David Spiegel
Journal:  Health Psychol       Date:  2004-11       Impact factor: 4.267

Review 2.  Cortisol pulsatility and its role in stress regulation and health.

Authors:  Elizabeth A Young; James Abelson; Stafford L Lightman
Journal:  Front Neuroendocrinol       Date:  2004-07       Impact factor: 8.606

3.  Increasing correlations between personality traits and cortisol stress responses obtained by data aggregation.

Authors:  J C Pruessner; J Gaab; D H Hellhammer; D Lintz; N Schommer; C Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  1997-11       Impact factor: 4.905

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Stress hormone-mediated invasion of ovarian cancer cells.

Authors:  Anil K Sood; Robert Bhatty; Aparna A Kamat; Charles N Landen; Liz Han; Premal H Thaker; Yang Li; David M Gershenson; Susan Lutgendorf; Steven W Cole
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.

Authors:  T Nakane; T Szentendrei; L Stern; M Virmani; J Seely; G Kunos
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

7.  Estimating between- and within-individual variation in cortisol levels using multilevel models.

Authors:  Daniel J Hruschka; Brandon A Kohrt; Carol M Worthman
Journal:  Psychoneuroendocrinology       Date:  2005-08       Impact factor: 4.905

8.  Levels and variability of daily life cortisol secretion in major depression.

Authors:  Frenk Peeters; Nancy A Nicolson; Johannes Berkhof
Journal:  Psychiatry Res       Date:  2004-04-15       Impact factor: 3.222

9.  Flattened cortisol rhythms in metastatic breast cancer patients.

Authors:  Heather C Abercrombie; Janine Giese-Davis; Sandra Sephton; Elissa S Epel; Julie M Turner-Cobb; David Spiegel
Journal:  Psychoneuroendocrinology       Date:  2004-09       Impact factor: 4.905

10.  Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens.

Authors:  Y Touitou; A Bogdan; F Lévi; M Benavides; A Auzéby
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more
  6 in total

Review 1.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

2.  Concurrent and prospective associations between HPA axis activity and depression symptoms in newlywed women.

Authors:  Fiona Ge; Paula R Pietromonaco; Casey J DeBuse; Sally I Powers; Douglas A Granger
Journal:  Psychoneuroendocrinology       Date:  2016-07-22       Impact factor: 4.905

Review 3.  Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis.

Authors:  Emma K Adam; Meghan E Quinn; Royette Tavernier; Mollie T McQuillan; Katie A Dahlke; Kirsten E Gilbert
Journal:  Psychoneuroendocrinology       Date:  2017-05-24       Impact factor: 4.905

4.  Intraindividual Cortisol Variability and Psychological Functioning in Caregivers of Hematopoietic Stem Cell Transplant Patients.

Authors:  Timothy S Sannes; Susan K Mikulich-Gilbertson; Crystal L Natvig; Mark L Laudenslager
Journal:  Psychosom Med       Date:  2016 Feb-Mar       Impact factor: 4.312

5.  Stress management reduces intraindividual cortisol variability, while not impacting other measures of cortisol rhythm, in a group of women at risk for breast cancer.

Authors:  Timothy S Sannes; Emily Dolan; Denise Albano; Rachel M Ceballos; Bonnie A McGregor
Journal:  J Psychosom Res       Date:  2015-09-28       Impact factor: 3.006

6.  Psychiatric comorbidities among endometrial cancer survivors in South Korea: a nationwide population-based, longitudinal study.

Authors:  Jaesung Heo; Mison Chun; Young Taek Oh; O Kyu Noh
Journal:  J Gynecol Oncol       Date:  2018-11-07       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.